Ryan Philip Jajosky, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocyte Transfusion | 15 | 2023 | 565 | 3.720 |
Why?
|
| Malaria, Falciparum | 8 | 2023 | 1077 | 2.990 |
Why?
|
| Exchange Transfusion, Whole Blood | 4 | 2020 | 59 | 2.700 |
Why?
|
| Babesiosis | 4 | 2023 | 92 | 2.550 |
Why?
|
| Erythrocytes | 15 | 2023 | 2418 | 2.430 |
Why?
|
| Isoantibodies | 11 | 2024 | 674 | 1.520 |
Why?
|
| ABO Blood-Group System | 5 | 2024 | 380 | 1.440 |
Why?
|
| Students, Medical | 5 | 2023 | 1930 | 1.300 |
Why?
|
| Pathology | 2 | 2021 | 270 | 1.080 |
Why?
|
| Blood Component Removal | 2 | 2017 | 132 | 1.080 |
Why?
|
| Malaria, Cerebral | 2 | 2017 | 136 | 1.060 |
Why?
|
| Isoantigens | 7 | 2023 | 552 | 1.030 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2017 | 130 | 1.020 |
Why?
|
| Babesia microti | 2 | 2023 | 31 | 1.010 |
Why?
|
| Career Choice | 3 | 2022 | 756 | 0.990 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2023 | 62 | 0.870 |
Why?
|
| Plasmodium falciparum | 5 | 2023 | 1742 | 0.860 |
Why?
|
| Blood Group Antigens | 4 | 2024 | 187 | 0.810 |
Why?
|
| Anemia, Sickle Cell | 3 | 2020 | 1064 | 0.790 |
Why?
|
| Parasites | 1 | 2023 | 160 | 0.730 |
Why?
|
| Internship and Residency | 4 | 2022 | 5877 | 0.700 |
Why?
|
| Erythrocyte Count | 1 | 2019 | 157 | 0.640 |
Why?
|
| Kernicterus | 1 | 2017 | 11 | 0.610 |
Why?
|
| Elliptocytosis, Hereditary | 1 | 2017 | 29 | 0.600 |
Why?
|
| Bernard-Soulier Syndrome | 1 | 2017 | 7 | 0.590 |
Why?
|
| Hyperbilirubinemia, Neonatal | 1 | 2017 | 30 | 0.590 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2018 | 94 | 0.580 |
Why?
|
| Blood Group Incompatibility | 2 | 2019 | 136 | 0.580 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2017 | 121 | 0.570 |
Why?
|
| Medical Records | 2 | 2020 | 1408 | 0.570 |
Why?
|
| Blood Banks | 1 | 2017 | 108 | 0.550 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2018 | 210 | 0.550 |
Why?
|
| Specialty Boards | 1 | 2017 | 235 | 0.510 |
Why?
|
| Pathology, Clinical | 1 | 2017 | 375 | 0.450 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2023 | 1066 | 0.440 |
Why?
|
| Antigens | 4 | 2023 | 1446 | 0.440 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 1117 | 0.410 |
Why?
|
| Fibroma | 1 | 2013 | 190 | 0.390 |
Why?
|
| Parasitemia | 2 | 2023 | 165 | 0.380 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 699 | 0.360 |
Why?
|
| Tricuspid Valve | 1 | 2013 | 413 | 0.350 |
Why?
|
| Heart Neoplasms | 1 | 2013 | 362 | 0.340 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 2373 | 0.320 |
Why?
|
| Hemophilia A | 2 | 2022 | 360 | 0.300 |
Why?
|
| Anemia | 1 | 2017 | 1508 | 0.290 |
Why?
|
| Complement C3 | 2 | 2020 | 451 | 0.290 |
Why?
|
| Galectins | 2 | 2024 | 295 | 0.240 |
Why?
|
| Galectin 4 | 1 | 2024 | 36 | 0.230 |
Why?
|
| Rho(D) Immune Globulin | 1 | 2023 | 34 | 0.220 |
Why?
|
| Schools, Medical | 2 | 2022 | 878 | 0.220 |
Why?
|
| Humans | 37 | 2024 | 761326 | 0.220 |
Why?
|
| Antibodies | 2 | 2023 | 2421 | 0.210 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 1555 | 0.210 |
Why?
|
| Maine | 1 | 2023 | 147 | 0.210 |
Why?
|
| Antigenic Modulation | 2 | 2021 | 11 | 0.210 |
Why?
|
| Connecticut | 1 | 2023 | 364 | 0.200 |
Why?
|
| Clodronic Acid | 1 | 2022 | 59 | 0.200 |
Why?
|
| Germinal Center | 2 | 2022 | 380 | 0.200 |
Why?
|
| Factor VIII | 2 | 2022 | 349 | 0.190 |
Why?
|
| Duffy Blood-Group System | 1 | 2021 | 58 | 0.190 |
Why?
|
| Papua New Guinea | 1 | 2020 | 46 | 0.180 |
Why?
|
| Blood Donors | 1 | 2023 | 345 | 0.180 |
Why?
|
| Blood Grouping and Crossmatching | 2 | 2019 | 100 | 0.180 |
Why?
|
| Benin | 1 | 2020 | 11 | 0.180 |
Why?
|
| Antibody Formation | 3 | 2020 | 1397 | 0.170 |
Why?
|
| Pulmonary Embolism | 1 | 2013 | 2566 | 0.170 |
Why?
|
| United States | 7 | 2022 | 72317 | 0.170 |
Why?
|
| Forms and Records Control | 1 | 2020 | 158 | 0.170 |
Why?
|
| Hemostatics | 1 | 2022 | 241 | 0.170 |
Why?
|
| Immunization | 1 | 2023 | 1226 | 0.160 |
Why?
|
| Babesia | 1 | 2018 | 29 | 0.160 |
Why?
|
| Hemolysis | 2 | 2019 | 424 | 0.160 |
Why?
|
| Leukostasis | 1 | 2017 | 23 | 0.150 |
Why?
|
| Asia, Southeastern | 1 | 2017 | 114 | 0.150 |
Why?
|
| Erythropoiesis | 1 | 2021 | 682 | 0.150 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 117 | 0.150 |
Why?
|
| Accreditation | 1 | 2021 | 473 | 0.150 |
Why?
|
| Leukapheresis | 1 | 2017 | 134 | 0.150 |
Why?
|
| Research Support as Topic | 1 | 2021 | 697 | 0.140 |
Why?
|
| Receptors, IgG | 1 | 2020 | 559 | 0.140 |
Why?
|
| Nepal | 1 | 2018 | 305 | 0.140 |
Why?
|
| Nigeria | 1 | 2020 | 770 | 0.140 |
Why?
|
| B-Lymphocytes | 2 | 2021 | 4764 | 0.140 |
Why?
|
| Specialization | 1 | 2021 | 779 | 0.130 |
Why?
|
| Medical History Taking | 1 | 2020 | 773 | 0.130 |
Why?
|
| Mastoiditis | 1 | 2015 | 37 | 0.120 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 1376 | 0.120 |
Why?
|
| Creatinine | 2 | 2018 | 1899 | 0.120 |
Why?
|
| Animals | 16 | 2024 | 168388 | 0.120 |
Why?
|
| Sarcoma, Myeloid | 1 | 2015 | 51 | 0.120 |
Why?
|
| Graft Rejection | 2 | 2018 | 4446 | 0.120 |
Why?
|
| Immune Tolerance | 1 | 2023 | 2300 | 0.120 |
Why?
|
| Glycine | 1 | 2017 | 666 | 0.110 |
Why?
|
| Salvage Therapy | 1 | 2020 | 1264 | 0.110 |
Why?
|
| Female | 14 | 2023 | 392485 | 0.110 |
Why?
|
| Antimalarials | 1 | 2020 | 907 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2019 | 1567 | 0.110 |
Why?
|
| Kidney Transplantation | 2 | 2018 | 4236 | 0.100 |
Why?
|
| Hospitals, Teaching | 1 | 2017 | 1156 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2024 | 3060 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2820 | 0.100 |
Why?
|
| Heart Arrest, Induced | 1 | 2013 | 359 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7389 | 0.100 |
Why?
|
| Facial Paralysis | 1 | 2015 | 345 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2023 | 26211 | 0.090 |
Why?
|
| Blood Transfusion | 1 | 2017 | 1299 | 0.090 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 1463 | 0.090 |
Why?
|
| Malaria | 1 | 2020 | 1227 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 1861 | 0.090 |
Why?
|
| Curriculum | 1 | 2023 | 3741 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2018 | 4371 | 0.080 |
Why?
|
| Male | 9 | 2021 | 360621 | 0.080 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 1626 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8526 | 0.080 |
Why?
|
| Angiography | 1 | 2013 | 1599 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2013 | 621 | 0.070 |
Why?
|
| Neoplasms, Second Primary | 1 | 2015 | 1051 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2013 | 1471 | 0.070 |
Why?
|
| Immunoglobulin M | 2 | 2022 | 1530 | 0.070 |
Why?
|
| Mortality | 1 | 2018 | 2898 | 0.070 |
Why?
|
| Heparin | 1 | 2013 | 1633 | 0.070 |
Why?
|
| Immunoglobulin G | 3 | 2023 | 4550 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2017 | 2746 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2021 | 3429 | 0.060 |
Why?
|
| Mice | 9 | 2023 | 81474 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2017 | 3613 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 22154 | 0.060 |
Why?
|
| Molecular Mimicry | 1 | 2024 | 213 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 3075 | 0.050 |
Why?
|
| Phenotype | 1 | 2020 | 16603 | 0.050 |
Why?
|
| Echocardiography | 1 | 2013 | 4991 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2020 | 64645 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11070 | 0.040 |
Why?
|
| Child | 2 | 2020 | 80156 | 0.040 |
Why?
|
| Kell Blood-Group System | 1 | 2018 | 21 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2024 | 983 | 0.040 |
Why?
|
| Complement C5 | 1 | 2018 | 106 | 0.040 |
Why?
|
| Receptors, Complement 3b | 1 | 2018 | 135 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2018 | 3701 | 0.040 |
Why?
|
| Kynurenine | 1 | 2018 | 141 | 0.040 |
Why?
|
| Swine | 2 | 2018 | 5915 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1825 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2018 | 393 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2024 | 984 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2021 | 2625 | 0.030 |
Why?
|
| Granulocytes | 1 | 2017 | 552 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2018 | 788 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14409 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18234 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2017 | 961 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2019 | 664 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 605 | 0.030 |
Why?
|
| Adult | 3 | 2017 | 221122 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 1170 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2017 | 1597 | 0.030 |
Why?
|
| Middle Aged | 2 | 2017 | 220774 | 0.030 |
Why?
|
| Spleen | 1 | 2018 | 2296 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 1943 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2013 | 23981 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39108 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1440 | 0.020 |
Why?
|
| Protein Binding | 1 | 2024 | 9351 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2024 | 4234 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 1842 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20555 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 1875 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2018 | 4810 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2413 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2018 | 2481 | 0.020 |
Why?
|
| Aged | 2 | 2017 | 169179 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9534 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2021 | 18962 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 7597 | 0.010 |
Why?
|
| Cytokines | 1 | 2018 | 7390 | 0.010 |
Why?
|
| Kidney | 1 | 2018 | 7049 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12972 | 0.010 |
Why?
|